NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

Amylyx to Reveal Phase 3 LUCIDITY Results for Avexitide Tomorrow – Stock Jumps on Clear Timeline

Topline data from Amylyx’s Phase 3 LUCIDITY trial of avexitide for PBH arrives August 18. Prior results and unmet need fuel optimism.

Amylyx to Reveal Phase 3 LUCIDITY Results for Avexitide Tomorrow – Stock Jumps on Clear Timeline
Credit: Amylyx Pharmaceuticals
Already have an account? Sign in.
08/17/2026 · 4:49 PM
AMLX
/ Don’t stop at just one post.

Related↓

Amylyx Drug Cuts Dangerous Low Blood Sugar Episodes After Weight-Loss Surgery in Key Trial
Featured/ 08/18/2026 · 7:27 AM

Amylyx Drug Cuts Dangerous Low Blood Sugar Episodes After Weight-Loss Surgery in Key Trial

Amylyx’s avexitide reduced severe low blood sugar episodes by 55% in a Phase 3 trial for post-bariatric hypoglycemia. First potential treatment nears FDA filing.

/ Subscriber only
/ Read more

Feed↓

Haemonetics Lands Non-Exclusive Deal with Major Plasma Collector CSL
08/18/2026 · 9:05 AM

Haemonetics Lands Non-Exclusive Deal with Major Plasma Collector CSL

Haemonetics enters a non-exclusive supply deal with CSL Plasma for NexSys PCS devices with Persona PLUS technology and disposables in the U.S.

/ Subscriber only
Nuvation Bio: JPMorgan Sees Strong Ibtrozi Launch and Pipeline Upside
08/18/2026 · 8:36 AM

Nuvation Bio: JPMorgan Sees Strong Ibtrozi Launch and Pipeline Upside

JPMorgan initiates Nuvation Bio at Overweight with $13 target, citing durable first-line adoption of Ibtrozi in ROS1+ lung cancer.

/ Subscriber only
Klarna Beats Q2 Expectations but Shares Fall on Lowered Full-Year GMV Outlook
Featured/ 08/18/2026 · 7:58 AM

Klarna Q2 Profit Beat Overshadowed by Trimmed Volume Forecast and Leadership Changes

Klarna shares dropped after trimming full-year GMV guidance, despite a strong Q2 profit of $9M, 27% revenue growth, and higher margins.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe